M&T Bank Corp Abb Vie Inc. Transaction History

M&T Bank Corp

$28.6 Billion
Q1 2024

A detailed history of M&T Bank Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, M&T Bank Corp holds 979,445 shares of ABBV stock, worth $168 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

979,445

Previous 966,580 1.33%

Holding current value

$168 Million

Previous $150 Million 19.07%

% of portfolio

0.62%

Previous 0.55%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$159.82 - $182.1 $2.06 Million - $2.34 Million	12,865 Added 1.33%	979,445 $178 Million
Q4 2023 Feb 06, 2024	BUY	$137.6 - $154.97 $481,049 - $541,775	3,496 Added 0.36%	966,580 $150 Million
Q3 2023 Nov 02, 2023	BUY	$133.59 - $154.65 $1.35 Million - $1.56 Million	10,105 Added 1.06%	963,084 $144 Million
Q2 2023 Aug 09, 2023	BUY	$132.51 - $164.9 $18.4 Million - $22.9 Million	138,661 Added 17.03%	952,979 $128 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $11.3 Million - $13 Million	78,076 Added 10.6%	814,318 $130 Million

Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $641,481 - $769,305	4,638 Added 0.63%	736,363 $119 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $16,735 - $20,070	-121 Reduced 0.02%	736,242 $119 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $2.58 Million - $2.96 Million	19,198 Added 2.69%	731,725 $94.6 Million
Q2 2022 Aug 05, 2022	BUY	$137.62 - $174.96 $5.08 Million - $6.45 Million	36,878 Added 5.46%	712,527 $103 Million
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $555,503 - $689,223	4,209 Added 0.63%	675,649 $110 Million
Q4 2021 Feb 07, 2022	SELL	$107.43 - $135.93 $111,297 - $140,823	-1,036 Reduced 0.15%	671,440 $90.9 Million
Q3 2021 Oct 28, 2021	SELL	$106.4 - $120.78 $835,878 - $948,847	-7,856 Reduced 1.15%	672,476 $72.5 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $2.84 Million - $3.16 Million	-26,980 Reduced 3.81%	680,332 $76.6 Million
Q1 2021 May 06, 2021	SELL	$102.3 - $112.62 $4.04 Million - $4.45 Million	-39,526 Reduced 5.29%	707,312 $76.5 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $2.58 Million - $3.48 Million	-32,031 Reduced 4.11%	746,838 $80 Million
Q3 2020 Nov 06, 2020	BUY	$85.91 - $100.83 $1.28 Million - $1.51 Million	14,928 Added 1.95%	778,869 $68.2 Million
Q2 2020 Jul 29, 2020	BUY	$73.37 - $98.18 $1.34 Million - $1.79 Million	18,257 Added 2.45%	763,941 $75 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $1.67 Million - $2.54 Million	-25,937 Reduced 3.36%	745,684 $56.8 Million
Q4 2019 Feb 07, 2020	BUY	$72.13 - $90.25 $169,649 - $212,268	2,352 Added 0.31%	771,621 $68.3 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $2.29 Million - $2.75 Million	-36,382 Reduced 4.52%	769,269 $58.3 Million
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $14.7 Million - $18.8 Million	-223,901 Reduced 21.75%	805,651 $58.6 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $10.2 Million - $12.1 Million	-132,738 Reduced 11.42%	1,029,552 $83 Million
Q4 2018 Feb 01, 2019	SELL	$77.85 - $96.01 $3.26 Million - $4.02 Million	-41,874 Reduced 3.48%	1,162,290 $107 Million
Q3 2018 Nov 09, 2018	SELL	$88.91 - $98.84 $2.32 Million - $2.58 Million	-26,089 Reduced 2.12%	1,204,164 $114 Million
Q2 2018 Aug 10, 2018	SELL	$89.78 - $106.23 $233,697 - $276,516	-2,603 Reduced 0.21%	1,230,253 $114 Million
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $3.86 Million - $5.16 Million	-41,920 Reduced 3.29%	1,232,856 $117 Million
Q4 2017 Feb 06, 2018	SELL	$89.56 - $98.21 $2.76 Million - $3.02 Million	-30,769 Reduced 2.36%	1,274,776 $123 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $1.46 Million - $1.87 Million	20,970 Added 1.63%	1,305,545 $116 Million
Q2 2017 Aug 11, 2017	BUY	N/A	1,284,575	1,284,575 $93.1 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account